Pharmaceutical giant Gilead Sciences has awarded over $22 million in grants for 12 HIV-cure-focused research projects. The grantees’ efforts fall into three categories: research that analyzes the HIV community’s perspectives of cure research, animal studies of HIV cure methods and studies into translating cure research into real-world use. A range of community-based groups, academic labs and nonprofits received the grants, including: Massachusetts General Hospital; Fred Hutchinson Cancer Research Center in Seattle; Johns Hopkins University School of Medicine; Case Western Reserve University School of Medicine; other academic labs in Zurich, Denmark, Paris and South Africa; AIDS Foundation of Chicago; Project Inform in San Francisco; and My Brother’s Keeper in Jackson, Mississippi. Much of the medical research will focus on ways to identify, reduce and possibly eliminate the viral reservoir, the presence of which prevents standard HIV treatment from curing the virus.
![](https://cdn3.poz.com/27446_scientists-iStock-5474185801.jpg_c70f1546-efe6-4e31-9c2a-8ffc52b0784f.jpeg)
![](https://cdn3.poz.com/27446_scientists-iStock-5474185801.jpg_c70f1546-efe6-4e31-9c2a-8ffc52b0784f.jpeg)
Istock (Model(s) used for illustrative purposes only)
Comments
Comments